329 related articles for article (PubMed ID: 34477080)
21. CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule.
Xiao A; Beatty CJ; Choudhary S; Akilov OE
Hematol Rep; 2023 Sep; 15(3):513-517. PubMed ID: 37754668
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy.
Nicolay JP; Wobser M
J Dtsch Dermatol Ges; 2016 Dec; 14(12):1207-1224. PubMed ID: 27992127
[TBL] [Abstract][Full Text] [Related]
23. Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
Kraft RM; Ansell SM; Villasboas JC; Bennani NN; Wang Y; Habermann TM; Thanarajasingam G; Lester SC; Macon W; Inwards DJ; Porrata LF; Micallef IN; Witzig TE; Thompson CA; Johnston PB; Nowakowski GS; Lin Y; Paludo J
Hematol Oncol; 2021 Dec; 39(5):658-663. PubMed ID: 34453851
[TBL] [Abstract][Full Text] [Related]
24. A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma.
Awad M; Holzwanger E; Jubbal S
Case Rep Dermatol Med; 2020; 2020():8310602. PubMed ID: 32318298
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
[TBL] [Abstract][Full Text] [Related]
27. What is new about primary cutaneous B cell lymphomas.
Blanchard M; Hoetzenecker W; Blanchard G; Guenova E
Ital J Dermatol Venerol; 2023 Jun; 158(3):205-216. PubMed ID: 37278499
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
Uccella S; Goteri G; Maiorana A; Donati V; Tibiletti MG; Magnoli F; Facchi S; Merchiori D; Morsia E; Papotti R; Bettelli S; Forti E; Galimberti S; Rupoli S; Filosa A; Dardanis D; Bomben R; Braglia L; Pozzi S; Sacchi S
Hum Pathol; 2023 Jun; 136():44-55. PubMed ID: 36997030
[TBL] [Abstract][Full Text] [Related]
29. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
Nockowski P; Woźniak Z; Reich A; Maj J
Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
[TBL] [Abstract][Full Text] [Related]
30. CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Papoudou-Bai A; Marinos L; Vassou A; Kapsali E; Kanavaros P
Case Rep Dermatol Med; 2019; 2019():3730915. PubMed ID: 30792929
[TBL] [Abstract][Full Text] [Related]
31. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; van Wezel T; van Eijk R; Ruano D; Tensen CP; Hauben E; Woei-A-Jin FJSH; Busschots AM; van den Berg A; Diepstra A; Vermeer MH; Vermaat JSP
Virchows Arch; 2022 Mar; 480(3):667-675. PubMed ID: 35028710
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
[TBL] [Abstract][Full Text] [Related]
33. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract][Full Text] [Related]
34. Programmed death-1 expression in cutaneous B-cell lymphoma.
Çetinözman F; Koens L; Jansen PM; Willemze R
J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment.
Chen ST; Barnes J; Duncan L
Semin Cutan Med Surg; 2018 Mar; 37(1):49-55. PubMed ID: 29719020
[TBL] [Abstract][Full Text] [Related]
37. Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma.
Lang CCV; Ramelyte E; Dummer R
Front Oncol; 2020; 10():1163. PubMed ID: 32850331
[No Abstract] [Full Text] [Related]
38. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
Tsang HC; Mathew S; Magro CM
Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
